Work

Supplementary Figure 1 from A Phase II Study Investigating Cabozantinib in Patients with Refractory Metastatic Colorectal Cancer (AGICC 17CRC01)

Year: 2023

Type: supplementary-materials

Abstract: KM curves for PIK3CA mutant subjects.

DOI: 10.1158/2767-9764.22545647

Authors: Aaron J. Scott, Atrayee Basu Mallick, Efrat Dotan, Steven J. Cohen, Philip J. Gold, Howard S. Hochster, Somasundaram Subramaniam, Afsaneh Barzi, George S. Watts, Patrick J. Blatchford, Wells A. Messersmith

Language: English

Topic: Colorectal Cancer Treatments and Studies

Subfield: Oncology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: gold

OpenAlex ID: W4362532952

Cites:

Cited by:

Related to: 10